← Nutrients & foods

Other compounds & fats · FROM DR. PURSER’S TEACHING

PQQ (Pyrroloquinoline Quinone)

A compound sold in supplements; it is not an established essential human vitamin.

Based on teaching by Dan Purser, MD. How we prepare these guides

Updated Sep 23, 2026 · Educational reference

THE TEACHING CONNECTION

A teaching category, not a deficiency diagnosis

A teaching category, not a deficiency diagnosis

Dr. Purser’s course places PQQ in its mitochondrial and brain-support category, near CoQ10 and phosphatidylserine. The discussion concerns a proposed support approach; it does not establish an essential dietary requirement or a recognized PQQ deficiency syndrome.

Putting the pieces together

PQQ is part of a wider conversation about cellular energy and nutrients. If you are considering it, review what you have already tried and what you hope to improve. Fatigue alone does not show that you need PQQ, and it is not a proven way to remove artery plaque.

How supplementation is approached

Dr. Purser places PQQ and Brite Brain-style products in mitochondrial and cognitive-support discussions. Identify the complete formula and check overlap with CoQ10 or other energy products. PQQ has no established dietary deficiency syndrome and should not be described as removing brain plaque.

What symptoms can—and cannot—tell you

There is no established dietary deficiency syndrome for this specific botanical or compound. Symptoms are not evidence that you need this supplement.

Food sources

Small amounts have been reported in various foods; a human dietary requirement has not been established.

Supplement forms

PQQ is sold alone or with other mitochondrial-support ingredients. Check Brite Brain or another combination product for overlap.

A question to bring to your visit

What is the specific goal of including PQQ, and how will benefit and tolerability be evaluated?

What to track and reassess

Choose a functional goal and track tolerance, sleep and actual use. Memory concerns still need an appropriate clinical evaluation.

From starting support to follow-up

If you and your clinician start a CMA replenishment plan, you may add one new product at a time, often waiting 3–7 days to see how you feel. A check-in is usually planned near ten weeks during an approximately 100-day period. Follow your written plan for amounts and timing. At follow-up, you may continue, change, or stop each item. This timetable does not automatically end longer-term support.

Names you may see

PQQ (Pyrroloquinoline Quinone) · Pyrroloquinoline Quinone